Dr. Raman Tuli
Participe à 2 sessions
Sessions auxquelles Dr. Raman Tuli participe
3:50 PM
3:50 PM
Faricimab in Neovascular Age-Related Macular Degeneration: One-Year Efficacy, Safety, and Durability in the Phase 3 TENAYA and LUCERNE Trials
8 minutes,
3:51 PM
- 3:59 PM
Partie de:
Rétine I
Paper Presentation | Présentation d'article
Dr. Raman Tuli (Conférencier.ère)
4:05 PM
4:05 PM
Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab(PDS) for Patients With Neovascular AMD
8 minutes,
4:07 PM
- 4:15 PM
Partie de:
Rétine II
Paper Presentation | Présentation d'article
Dr. Raman Tuli (Conférencier.ère)